Philips reports Q2 sales of EUR 5.9 billion and comparable sales growth of 3%, a 9% improvement in Adjusted EBITA to EUR 544 million and net income of EUR 431 million
Second-quarter highlights
- Comparable sales of the HealthTech portfolio continued to grow at 5%
- Adjusted EBITA amounted to EUR 544 million, or 9.3% of sales, compared to 8.4% of sales in Q2 2015
- EBITA totaled EUR 464 million, or 7.9% of sales, compared to 7.5% of sales in Q2 2015
- Income from operations (EBIT) amounted to EUR 376 million, compared to EUR 349 million in Q2 2015
- Net income amounted to EUR 431 million, including a EUR 144 million award from the Funai arbitration, compared to EUR 274 million in Q2 2015
- Operating cash flow of EUR 318 million, compared to EUR 186 million in Q2 2015, and a free cash inflow of EUR 127 million, compared to an outflow of EUR 30 million in Q2 2015